Page last updated: 2024-10-23

azathioprine and Coronary Restenosis

azathioprine has been researched along with Coronary Restenosis in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arruda, JA1
Costa, MA1
Brito, FS1
Tedesco, H1
Barbosa, AH1
Ribeiro, EP1
Pestana, JO1
Lima, VC1

Trials

1 trial available for azathioprine and Coronary Restenosis

ArticleYear
Effect of systemic immunosuppression on coronary in-stent intimal hyperplasia in renal transplant patients.
    The American journal of cardiology, 2003, Jun-01, Volume: 91, Issue:11

    Topics: Azathioprine; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Cyclosporine; Drug Therap

2003